BRCA2 and myeloproliferative neoplasm: Moreover, even in patients with sporadic MPN, the natural incidence of germline mutations in DSB repair genes would be expected to be at least 0.1–0.5% since this is the combined incidence of BRCA1 and BRCA2 mutations in the general population [24].